Please login to the form below

Not currently logged in
Email:
Password:

Belsomra

This page shows the latest Belsomra news and features for those working in and with pharma, biotech and healthcare.

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Merck gets Alzheimer’s label claim for insomnia drug Belsomra

Critically, unlike some other insomnia drugs like zolpidem, Belsomra doesn’t seem to lead to a significant increase in confusion and falls in people who are cognitively impaired. ... Peak sales of Belsomra are expected to reach around $500m, with the

Latest news

  • Relief as study finds no cardiovascular risk with Januvia Relief as study finds no cardiovascular risk with Januvia

    Meanwhile, first-in-class insomnia therapy Belsomra (suvorexant) and new antibiotic Zerbaxa (ceftolozane/tazobactam) also got off to a good start, according to chief executive Kenneth Frazier.

  • FDA approves Merck’s insomnia drug FDA approves Merck’s insomnia drug

    Belsomra is first orexin receptor antagonist available in US. People with the sleep disorder insomnia now have access to a new treatment option after the FDA approved Merck &Co's Belsomra. ... To cover the varying severity of the disorder, Belsomra is

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics